Playing catch up

July 2008
Pharmaceutical Representative;Jul2008, Vol. 13 Issue 7, p12
The article reports on the significance of antiretroviral drug treatments for AIDS in the U.S. United Nations (UN) officials report that 2.5 million people became infected with HIV, while only 1 million started to use vital antiretrovirus treatments. It notes that the burden of epidemics on households, communities and societies will continue to mount unless greater advances are made to reach those who need services.


Related Articles

  • Pharmaceuticalization: AIDS Treatment and Global Health Politics. Biehl, João // Anthropological Quarterly;Fall2007, Vol. 80 Issue 4, p1083 

    This article examines the political economy of pharmaceuticals that lies behind global AIDS treatment initiatives, revealing the possibilities and inequalities that come with a magic bullet approach to health care. It tells how Brazil, against all odds, became the first developing country to...

  • Development of Integrase Inhibitors of Quinolone Acid Derivatives for Treatment of AIDS: An Overview. Luo, Z. G.; Tan, J. J.; Zeng, Y.; Wang, C. X.; Hu, L. M. // Mini Reviews in Medicinal Chemistry;Oct2010, Vol. 10 Issue 12, p1046 

    No abstract available.

  • HIV: FROM DEATH SENTENCE TO CHRONIC DISEASE. Karpa, Kelly Dowhower // Drug Topics;10/6/2003, Vol. 147 Issue 19, p72 

    Focuses on antivirals and updated guidelines that offer new opportunities for pharmaceutical management of AIDS in the 21st century. Impact of combination therapy on HIV morbidity and mortality; Preferred antiretroviral drug regimens; Potential benefits of early therapy initiation; Risks of...

  • Late presenters to HIV care and treatment, identification of associated risk factors in HIV-1 infected Indian population. Mojumdar, Kamalika; Vajpayee, Madhu; Chauhan, Neeraj K.; Mendiratta, Sanjay // BMC Public Health;2010, Vol. 10 Issue 1, p416 

    Background: Timely access to antiretroviral therapy is a key to controlling HIV infection. Late diagnosis and presentation to care diminish the benefits of antiretrovirals and increase risk of transmission. We aimed to identify late presenters in patients sent for first CD4 T cell count after...

  • Impacto da terapia antirretroviral conforme diferentes consensos de tratamento da Aids no Brasil. De Rossi, Silvia Maria Gomes; Cesario, Eliane; Maluf, Pereira; Carvalho, Denise Siqueira; Ribeiro, Clea Elisa Lopes; Battaglin, Celia Regina Pissini // Pan American Journal of Public Health;Aug2012, Vol. 32 Issue 2, p117 

    Objective. Compare the characteristics of AIDS patients and treatment outcomes under three different antiretroviral treatment regimens advocated by the Ministry of Health of Brazil. Methods. Retrospective cohorts of patients who had survived up to five years after diagnosis were constructed. The...

  • Preferences for Characteristics of Antiretroviral Therapy Provision in Johannesburg, South Africa: Results of a Conjoint Analysis. Opuni, Marjorie; Bishai, David; Gray, Glenda E.; McIntyre, James A.; Martinson, Neil A. // AIDS & Behavior;Aug2010, Vol. 14 Issue 4, p807 

    A survey was administered to HIV-infected patients and a sample in Soweto and the Johannesburg inner city to measure preferences for antiretroviral therapy (ART) provision. The 25 to 49-year-old male and female respondents viewed 20 sets of three hypothetical ART clinic choices after reading...

  • The Abandoned Trials of Pre-Exposure Prophylaxis for HIV: What Went Wrong? Singh, Jerome A.; Mills, Edward J. // PLoS Medicine;Sep2005, Vol. 2 Issue 9, p824 

    Discusses the impact of irresponsible reporting and activism against the use of the oral antiretroviral drug tenofovir as a pre-exposure prophylaxis (PREP) for HIV/AIDS. Protests against trials of PREP; Concerns of the protestors; Threats to PREP trials.

  • AIDS Review. Harries, Anthony D.; Zachariah, Rony // Africa Health;Jan2013, Vol. 35 Issue 2, p41 

    Information about the XIX World AIDS Conference held Washington D.C. in July 2012 is presented. The conference, which was attended by 24,000 delegates, featured several issues discussed that focused on AIDS prevention. The event also highlighted the presentation on the strategic use of...

  • Health systems and older people with HIV and AIDS. Atun, R. A.; Gurol-Urganci, I.; McKee, M. // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;8/8/2009, Vol. 339 Issue 7716, p308 

    The authors reflect on the development of human immunodeficiency virus (HIV) and antiretroviral therapy. They compare the development of the therapy with that of the treatment for diabetes. They also commend the success of European countries, such as Denmark and France, in initiating...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics